Joint pain in a young child is so unexpected that families and sometimes clinicians chalk it up to growing pains, a sports injury, or a stubborn limp from a fall nobody remembers. By the time juvenile idiopathic arthritis (JIA) is diagnosed, the average UK child has been symptomatic for several months. The pattern is recognisable once you know what to look for, and recognising it early matters — both for the joints themselves and because of one specific complication, uveitis, which causes no early symptoms but can permanently damage vision.
Healthbooq (healthbooq.com) covers childhood health conditions across the early years.
What JIA Is
Juvenile idiopathic arthritis is not a single disease but a category. The label applies when:
- A child under sixteen has joint inflammation
- That inflammation has lasted at least six weeks
- No other cause has been identified
The "idiopathic" part is honest: in most cases we do not know why a child's immune system has decided to inflame their own joints. JIA is not the childhood version of adult rheumatoid arthritis (with one exception, below) — it has its own subtypes, its own course, and a substantially better outlook than parents fear when they first hear the word "arthritis."
The International League of Associations for Rheumatology (ILAR) splits JIA into seven subtypes, based on how many joints are involved, whether systemic features are present, and a couple of antibody results. The subtype matters because it predicts course, complications, and treatment.
The Subtypes Worth Knowing
Oligoarticular JIA — the most common, around half of UK cases. Four or fewer joints affected, typically a knee, ankle, or wrist. Mostly young girls, often ANA-positive on blood tests. The single most important fact about this subtype is its association with uveitis — up to 30% of children with oligoarticular JIA develop the silent eye inflammation. Eye screening is mandatory.
Polyarticular JIA, RF-negative — five or more joints. Hands, feet, and the larger joints. Also more common in girls. Doesn't usually have systemic features.
Polyarticular JIA, RF-positive — five or more joints with a positive rheumatoid factor blood test. This is the subtype that genuinely resembles adult rheumatoid arthritis. Tends to affect older girls and is more likely to cause erosive joint damage if not treated promptly.
Systemic JIA (Still's disease) — the dramatic one. Daily or twice-daily fever spikes to 39 °C or higher, with the child often perfectly well between fevers. A salmon-coloured rash that comes and goes with the fever. Swollen lymph nodes, sometimes an enlarged liver or spleen. Joint inflammation may not appear until weeks after the fever starts. Affects boys and girls equally. There is a serious complication called macrophage activation syndrome (MAS) — falling cell counts, persistent fever, very high ferritin — which is a paediatric emergency.
Enthesitis-related JIA and psoriatic JIA make up the rest.
What to Look For at Home
The most useful early signs:
- Morning stiffness that improves with movement. This is the pattern that distinguishes inflammatory from mechanical joint problems. A child who limps for the first hour after waking, then runs around normally by mid-morning, is showing classic inflammatory stiffness. Mechanical injuries are usually worse with use, not better.
- An asymmetric swollen joint. Compare the two knees, the two ankles. A subtly puffy or warm joint that the child has not really complained about — but on closer look is clearly bigger or warmer than the other side — is a flag.
- Reluctance to use a limb. Children rarely articulate joint pain the way adults do. They stop using the hand. They limp without saying why. They refuse to walk first thing.
- Repeated, unexplained "growing pains" only in specific joints. Real growing pains are typically diffuse, in the calves or thighs at night, and resolve fully by morning. Persistent pain in one joint is not growing pains.
- Daily spiking fever lasting more than two weeks, particularly with a rash that appears with the fever and fades when the fever drops — this is systemic JIA until proven otherwise and warrants urgent paediatric assessment.
A useful first step is to ask your GP for a paediatric or paediatric rheumatology referral if a joint has been swollen for more than a couple of weeks without obvious trauma, or if the morning-stiffness pattern is clear.
The Uveitis Question
This is the part that often surprises parents — and the reason eye screening is non-negotiable.
Anterior uveitis in JIA is silent in the early stages. The eye does not look red. The child does not complain of pain or blurred vision. Visual acuity is initially preserved. The diagnosis is made by an ophthalmologist using a slit lamp, looking for inflammatory cells floating in the front chamber of the eye.
Untreated chronic uveitis causes:
- Cataracts
- Glaucoma
- Band keratopathy (calcium deposits across the cornea)
- Permanent visual loss
Risk is highest in oligoarticular JIA and ANA-positive polyarticular JIA. The screening schedule, set out in BSPAR guidance, is typically every three months in the high-risk first few years after diagnosis, lengthening as risk falls.
When picked up early, uveitis usually responds to topical steroid drops, sometimes mydriatics, and — when it persists or becomes chronic — systemic immunosuppression (often methotrexate, sometimes biologics). The point of every-three-month screening is to catch it before it does damage.
Treatment
Care happens in a paediatric rheumatology service. The aim is full disease control — no swollen joints, no morning stiffness — not just symptom relief.
NSAIDs (naproxen, ibuprofen) for symptom control while the disease-modifying treatment kicks in. Useful, but on their own do not change the trajectory of the disease.
Intra-articular steroid injections. A workhorse of oligoarticular JIA — a single targeted injection into an inflamed joint can switch off the inflammation for months. In young children these are done under sedation or general anaesthetic, often combined with day-case ophthalmology examination.
Methotrexate. The standard disease-modifying drug. Once-weekly subcutaneous injection (better tolerated than oral tablets in children). Folic acid supplementation alongside reduces nausea and mouth ulcers. Regular blood monitoring for liver enzymes and full blood count. Effective in most subtypes; usually started early in polyarticular disease and in oligoarticular disease that does not respond to joint injections.
Biologic therapies. Anti-TNF agents (etanercept, adalimumab) and IL-6 inhibitors (tocilizumab, particularly for systemic JIA) have transformed outcomes for children whose disease does not respond adequately to methotrexate. They are used widely in current UK paediatric rheumatology practice.
Physiotherapy and occupational therapy run alongside the medication. The aim is preserving range of movement, muscle strength, and function. Children with chronic joint inflammation lose muscle mass quickly without active rehab.
Living With It — and the Long Picture
Modern treatment is genuinely effective. Most children with JIA participate in school, sport, and normal childhood activity, sometimes with adjustments around flares. Many children with oligoarticular JIA achieve remission, often by adulthood. Polyarticular and systemic subtypes are more variable; some carry on into adult rheumatology services.
A few practical points families consistently find helpful:
- Keep school informed. JIA can affect handwriting, PE, and stair-climbing on bad days. A simple letter from the rheumatology team makes adjustments straightforward.
- Children on methotrexate or biologics are mildly immunosuppressed — annual flu vaccination is recommended; live vaccines need specialist input.
- Flares often coincide with viral illnesses or stressful periods. Know what your child's flare looks like and contact the team early rather than waiting it out.
- Eye screening dates are not optional, even if the child is doing brilliantly in every other respect.
The diagnosis is hard to receive. The trajectory most families end up on, with good treatment, is much less hard than the word "arthritis" first suggests.
Key Takeaways
Juvenile idiopathic arthritis affects roughly one in 1,000 UK children — the most common chronic rheumatic condition in childhood. The classic warning signs are easy to mistake for growing pains: morning stiffness that improves with movement, a quiet limp on getting up, a swollen knee that nobody can quite remember bumping. The most important specialist hand-off after diagnosis is the eye clinic, because the silent uveitis that can come with JIA causes no symptoms until permanent damage has been done. Modern treatment is genuinely effective — most children play sport, live normally, and many achieve remission.
